Phenotype changes of the vascular smooth muscle cell regulate P2 receptor expression as measured by quantitative RT-PCR

Biochemical and Biophysical Research Communications

Volumn 248, Issue 3, 1998, Pages 864-870

  Erlinge, D ^a   Hou, M ^a   Webb, T E ^b   Barnard, E A ^b   Moller S ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

ATP; Competitive TR PCR; mRNA quantification; P2 receptors; Synthetic phenotype; UTP

Indexed keywords

MESSENGER RNA; PURINE P2X RECEPTOR; PURINE P2Y RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; VASCULAR SMOOTH MUSCLE;

ANIMALIA;

EID: 0032581365     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1998.9083     Document Type: Article

References (33)

1. Ralevic V., Burnstock G. Circulation. 84:1991;1-14.
2. Erlinge D. General Pharmacol. 31:1998;1-8.
3. North R. A., Barnard E. A. Current Opinion Neurobiology. 7:1997;346-357.
4. Thyberg J. Int. Rev. Cytology. 169:1996;183-265.
5. Erlinge D., Junping Y., Wahlestedt C., Edvinsson L. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 289:1995;135-149.
6. Pacaud P., Malam-Souley R., Loirand G., Desgranges C. Am. J. Physiol. 269:1995;H30-H36.
7. Webb T. E., Simon J., Krishek B. J., Bateson A. N., Smart T. G., King B. F., Burnstock G., Barnard E. A. FEBS Lett. 324:1993;219-225.
8. Lustig K. D., Shiau A. K., Brake A. J., Julius D. Proc. Natl. Acad. Sci. USA. 90:1993;5113-5117.
9. Erlinge D., Yoo H., Edvinsson L., Reis D. J., Wahlestedt C. Am. J. Physiol. 265:1993;H1089-H1097.
10. Valera S., Hussy N., Evans R. J., Adami N., North R. A., Surprenant A., Buell G. Nature. 371:1994;516-519.
11. Tokuyama Y., Hara M., Jones E. M. C., Fan Z., Bell G. I. Biochem. Biophys. Res. Commun. 211:1995;211-218.
12. Chen Z-P., Krull N., Xu S., Levy A., Lightman S. L. Endocrinology. 137:1996;5-1840.
13. Chang K., Hanaoka K., Kumada M., Takuwa Y. J. Biol. Chem. 270:1995;26152-26158.
14. Webb T. E., Henderson D., Roberts J. A., Barnard E. A. J. Neurochem. 1998.
15. Rasband W. S., Bright D. S. Microbeam Anal. Soc. J. 4:1995;137-149.
16. Menzo S., Bagnarelli P., Giacca M., Manzin A., Varaldo P. E., Clementi M. J. Clin. Microbiol. 30:1992;1752-1757.
17. Vrana S. L., Kluttz B. W., Vrana K. E. Mol. Brain Res. 34:1995;127-134.
18. Wang A. M., Doyle V. D., Mark D. F. Proc. Natl. Acad. Sci. USA. 86:1989;9717-9721.
19. Möller S., Adner M., Edvinsson L. Clin. Exp. Pharmacol. Physiol. 1998.
20. Evans R. J., Surprenant A., North R. A. The P2 Nucleotide Receptors. 1998;Humana Press, Totowa. p. 43-61.
21. Kitajima S., Ozaki H., Karaki H. Eur. J. Pharmacol. 266:1994;263-267.
22. Tawada Y, Furukawa K-I., Shigekawa M. J. Biochem. 102:1987;1499-1509.
23. von der Weid P-Y., Serebryakov V. N., Orallo F., Bergmann C., Snetkov V. A., Takeda K. Br. J. Pharmacol. 108:1993;638-645.
24. Miyagi Y., Kobayashi S., Nishimura J., Fukui M., Kanaide H. Br. J. Pharmacol. 118:1996;847-856.
25. Malam-Souley R., Seye C., Gadeau A-P., Loirand G., Pillois X., Campan M., Pacaud P., Desgranges C. J. Cell. Physiol. 166:1996;57-65.
26. von Kugelgen I., Starke K. Naunyn Schmiedebergs Arch. Pharmacol. 341:1990;538-546.
27. Saiag B., Milon D., Allain H., Rault B., Van den Driessche J. Blood Vessels. 27:1990;352-364.
28. Lazarowski E. R., Watt W. C., Stutts M. J., Boucher R. C., Harden T. K. Br. J. Pharmacol. 116:1995;1619-1627.
29. Koshiba M., Apasov S., Sverdlov V., Chen P., Erb L., Turner J. T., Weisman G. A., Sitkovsky. Proc. Natl. Acad. Sci. USA. 94:1997;831-836.
30. Turner J. T., Weisman G. A., Camden J. M. Am. J. Physiol. 273:1997;C1100-C1107.
31. Martin K. A., Kertesy S. B., Dubyak G. R. Mol. Pharmacol. 51:1997;97-108.
32. Nicholas R. A., Watt W. C., Lazarowski E. R., Li Q., Harden T. K. Mol. Pharmacol. 50:1996;224-229.
33. Harper S., Webb T. E., Charlton S. J., Leon L. N., Boarder M. R. Br. J. Pharmacol. 124:1998;703-710.